ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Equities
1541
CNE100006624
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.82 HKD | -0.29% | -1.14% | -53.78% |
24/06 | ImmuneOnco Biopharmaceuticals Gets IND Approval for NMOSDs Drug Trial in China | MT |
03/06 | ImmuneOnco Biopharmaceuticals Gets China's Phase 3 Trial Approval for Leukemia Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationChiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-53.78% | 664M | |
+15.96% | 122B | |
+18.92% | 113B | |
+18.95% | 26.49B | |
-23.38% | 19.4B | |
-19.03% | 16.24B | |
-19.93% | 15.4B | |
-46.14% | 15.15B | |
+64.96% | 14.93B | |
+4.89% | 13.52B |
- Stock Market
- Equities
- 1541 Stock
- News ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
- ImmuneOnco Biopharmaceuticals Gets IND Approval for NMOSDs Drug Trial in China